Researchers Advocate for Closer Monitoring of Patients With EoE

August 12th 2022, 1:30pm


A study of adult patients with eosinophilic esophagitis in remission showed that those who were followed more closely in the maintenance phase of treatment had fewer strictures and had their disease activity found earlier.

Targeted Outreach Efforts Meaningful for Patients With Lung Cancer

August 12th 2022, 1:13pm


Patients were more likely to accept intervention from a psychologist if they received regular questionnaires.

ACR Releases 2022 Vaccination Guideline Summary for Patients With RMDs

August 12th 2022, 12:26pm


The summary includes expanded indications for certain vaccines, approaches for live-attenuated vaccines, and medication management around the time of vaccination for patients with rheumatic and musculoskeletal diseases (RMDs).

Anti–PD-1 Therapy Likely Leads to Responses in Advanced ICC

August 11th 2022, 11:16pm


The therapy for intrahepatic cholangiocarcinoma (ICC) led to responses in about a quarter of patients and disease control in 85%.

Disease Burden of Alopecia Areata Greater in Lower-Income Countries

August 11th 2022, 6:14pm


Despite decreasing trends observed in the global burden of alopecia areata, low-income countries and ​​Western Sub-Saharan Africa regions continue to exhibit rising incidence and disability-adjusted life-years rates.

Bevacizumab Biosimilar Comparable to Reference Across Disease States

August 10th 2022, 9:15pm


The single-center study evaluated patients across multiple cancers to understand the utilization, safety, and financial outcomes of bevacizumab-awwb vs reference bevavizumab.

SLN Biopsy Promising for Long-term Metastatic Melanoma Control

August 10th 2022, 8:56pm


The usefulness of sentinel lymph node (SLN) biopsy was investigated among patients with melanoma and SLN metastases.

Race, Insurance Type Among Predictors of Depressive Symptoms in Atopic Dermatitis

August 10th 2022, 6:40pm


Most patients with atopic dermatitis had flunctuating levels of depressive symptoms, with having public or no insurance, more severe itch, and skin pain cited as additional predictors of adverse mental health outcomes.

What We’re Reading: Alzheimer Drug Setback; Rural Health Care Investment; Monkeypox Drug Delivery

August 10th 2022, 3:05pm


Acadia Pharmaceuticals’ pimavanserin (Nuplazid) was not extended by the FDA to include Alzheimer-related psychosis; HHS/Health Resources and Service Administration vow to strengthen rural health care; a new deal has the United States paying $26 million for Siga Technologies’ Tpoxx.

Heart Failure Prognosis Not Improved by Risk Score Prediction

August 10th 2022, 3:00pm


The REVEAL-HF study investigated using risk scores to improve patient outcomes through targeted interventions, including treatment initiation and intensity, end-of-life care, and hospitalization and mortality risks.